Rick Riemens, Senior scientist at Acerta Pharma B.V. (A member of the AstraZeneca Group)

Rick Riemens

Senior scientist at Acerta Pharma B.V. (A member of the AstraZeneca Group) | Ede, Gelderland, Netherlands

Profile last verified July 2026
Research Verified Profile Ede, Gelderland, Netherlands Vrije Universiteit Amsterdam (VU Amsterdam)
Verified

Personal Email

***@hotmail.com

Personal • High Confidence

Phone Number

(**) *** *** 271

Netherlands • Phone

Free account · No credit card · 5 profiles/month

Rick Riemens Socials
Rick Riemens Work Experience

Senior scientist at Acerta Pharma B.V. (A member of the AstraZeneca Group) in July 2022 - Present

PhD-student at Vrije Universiteit Amsterdam in July 2018 - June 2022

Research assistent at Vrije Universiteit Amsterdam in September 2017 - June 2018

See more See less

Research internship at Universiteit Utrecht in February 2017 - July 2017

Research internship at Vrije Universiteit Amsterdam in March 2016 - December 2016

Student Assistant at Vrije Universiteit Amsterdam / VU University Amsterdam in July 2015 - November 2015

Research Internship at Vrije Universiteit Amsterdam / VU University Amsterdam in September 2014 - June 2015

Research Internship at UMC Utrecht in February 2013 - July 2013

Rick Riemens Education

Vrije Universiteit Amsterdam (VU Amsterdam), Doctor of Philosophy - PhD, August 2026

Vrije Universiteit Amsterdam (VU Amsterdam), Master of Science (MSc), August 2026

HU University of Applied Sciences Utrecht (Hogeschool Utrecht), Bachelor of Applied Science (BASc), August 2026

Rick Riemens Skills
Microsoft Excel Microsoft Office English Dutch Chemistry Organic Chemistry
About Rick Riemens’s Current Company
Acerta Pharma B.V. (A member of the AstraZeneca Group)

Acerta Pharma is a European R&D centre of the AstraZeneca group dedicated to the discovery and development of novel innovative drugs for the treatment of haematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer. In 2016 AstraZeneca took a majority stake in the company and Acerta Pharma was fully acquired by AstraZeneca in 2021. We are working to develop new treatment options for patients with specific types of blood cancer. Together with our R&D colleagues of AstraZeneca in Gaithersburg, San Francisco, Boston (US), Gothenburg (SE) and Cambridge (UK) we are committed to innovative drug discovery and development, especially in the field of haematological oncology.

Discover more about Acerta Pharma B.V. (A member of the AstraZeneca Group)
Rick Riemens’s Colleagues
Gerjan Debruin

Gerjan Debruin

Nijmegen, Gelderland, Netherlands

Director Medicinal Chemistry at Acerta Pharma / Astrazeneca

Associate Director Medicinal Chemistry at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(August 2022 – Present)

OK

Olaf Kinzel

Netherlands

Head of Medicinal Chemistry at Acerta Pharma B.V. (A member of the AstraZeneca Group)

Senior Director Medicinal Chemistry at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(July 2022 – Present)

RS

Renu Sorte

Eindhoven, North Brabant, Netherlands

Global Study Manager at Acerta B.V

Global Study Manager at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(October 2025 – Present)

Gemma Satterthwaite

Gemma Satterthwaite

United Kingdom

Strategic Oncology Leader | Driving Portfolio Growth and Commercial Excellence | Board Member

Member of The Supervisory Board at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(May 2022 – Present)

Simone Giorgi

Simone Giorgi

Nieuwegein, Utrecht, Netherlands

Senior Scientist Medicinal Chemistry @ AstraZeneca | Drug Discovery Pipeline Innovation

Worked on drug discovery program from target validation to candidate nomination
Main responsibilities:
Pipeline Strategy & Decision Making: Lead medicinal chemistry design meetings, driving the critical decision-making process for compound prioritization and Go or No-Go asset ...

Nico Stam

Nico Stam

Eindhoven, North Brabant, Netherlands

Executive Strategy & Business Consultant Life Sciences

RegMed XB ( Regenerative Medicine Crossing Borders) represents a public-private partnership institute of Dutch and Flemish universities, Health Foundations, companies and government bodies focusing on translating regenerative medicine research moving therapies for major chroni...

Search similar profiles
Frequently asked questions about Rick Riemens

What is Rick Riemens email address?

Email Rick Riemens at [email protected], [email protected] and [email protected]. This email is the most updated Rick Riemens's email found in 2026.

How to contact Rick Riemens?

To contact Rick Riemens send an email to [email protected], [email protected] or [email protected]. (updated on July 2026)

What company does Rick Riemens work for?

Rick Riemens works for Acerta Pharma B.V. (A member of the AstraZeneca Group).

What is Rick Riemens's role at Acerta Pharma B.V. (A member of the AstraZeneca Group)?

Rick Riemens is Senior scientist

What industry does Rick Riemens work in?

Rick Riemens works in the Research industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free